Not Sorry Migraine Attack Tee - Unisex Ultra Cotton Shirt
-
Product Info
Migraine Attack
I Am Not Sorry For What I Said During My Migraine Attack
Make a bold statement with our witty and relatable "I Am Not Sorry" migraine t-shirt. This conversation-starting design perfectly captures the raw honesty that comes with experiencing a migraine attack...because sometimes pain makes us more candid than we'd normally be. The eye-catching typography in teal, red, and beige pops against the charcoal heather fabric, while our adorable angry brain character adds just the right touch of humor to a serious subject.
Perfect for anyone living with migraine or those who love someone who does, this shirt combines humor with the all-too-real experience of migraine attacks. It's an ideal gift for those days when you need to warn others that the filter between your brain and mouth might be temporarily offline due to neurological distress. Wear it proudly as a badge of resilience and a gentle reminder that sometimes, pain deserves a pass on social niceties.
✓ Premium Quality
- Seamless design without side seams
- Highly elastic ribbed knit collar
- Stabilizing shoulder tape prevents stretching
- Environmentally-friendly cotton with vintage feel
- Tear-away label for ultimate comfort
♺ Care Instructions
- Machine wash cold (max 30°C/90°F)
- Non-chlorine bleach as needed
- Do not tumble dry
- Do not iron
- Do not dry clean
Size Guide
Measurement S M L XL 2XL 3XL 4XL 5XL Width (in) 18.00 20.00 22.00 24.00 26.00 28.00 30.00 32.00 Length (in) 28.00 29.00 30.00 31.00 32.00 33.00 34.00 35.00 Sleeve length (in) 15.62 17.37 18.75 20.00 21.50 22.87 24.25 25.50 All measurements may vary by ±1.5 inches.
Express yourself with humor and honesty while staying comfortable all day long!
Thu, Apr 24, 25
Clinical Predictors for Efficacy of Erenumab (Aimovig) for Migraine
Discover key predictors of Aimovig (erenumab) response in migraine patients. This REFORM study reveals which patients benefit most from CGRP therapy and why timing matters. Evidence-based insights for better treatment...
Read MoreWed, Apr 23, 25
Effectiveness and Tolerability of Atogepant (Qulipta) in the Prevention of Migraine
STAR study shows atogepant (Qulipta) effectively reduces migraine days by 56.6% in real-world clinical practice, even for patients with previous treatment failures. Learn about this breakthrough.
Read MoreWed, Apr 23, 25
Impact of Visual Stimulus Complexity on Associative Learning in Migraine Patients
Groundbreaking research reveals how migraine patients process visual information differently. This 2025 study found that migraine patients take longer to process simple visual stimuli compared to complex images, which is...
Read More